ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,224,618 | -35.4% | 893,882 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $1,894,620 | +101761.3% | 779,679 | +141.5% | 0.00% | -50.0% |
| Q1 2023 | $1,860 | +7.4% | 322,876 | +66.7% | 0.00% | – |
| Q4 2022 | $1,732 | -99.9% | 193,687 | +84.5% | 0.00% | -100.0% |
| Q3 2022 | $1,493,000 | -42.8% | 105,000 | -41.2% | 0.00% | 0.0% |
| Q2 2022 | $2,609,000 | +161.2% | 178,666 | +257.3% | 0.00% | 0.0% |
| Q1 2022 | $999,000 | +461.2% | 50,000 | +119.8% | 0.00% | – |
| Q3 2021 | $178,000 | -81.9% | 22,747 | -76.1% | 0.00% | -100.0% |
| Q2 2021 | $981,000 | -58.3% | 95,352 | -47.0% | 0.00% | -50.0% |
| Q1 2021 | $2,355,000 | +659.7% | 180,041 | +715.5% | 0.00% | – |
| Q4 2020 | $310,000 | – | 22,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |